This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant glioma
Molecular Medicine Open Access 28 January 2021
-
CPEM: Accurate cancer type classification based on somatic alterations using an ensemble of a random forest and a deep neural network
Scientific Reports Open Access 15 November 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Chen, R. et al. Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H glioma. Proc. Natl Acad. Sci. USA http://dx.doi.org/10.1073/pnas.1409653111 (2014)
Rights and permissions
About this article
Cite this article
Lokody, I. Reprogramming metabolic flux in glioma. Nat Rev Cancer 14, 706–707 (2014). https://doi.org/10.1038/nrc3840
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrc3840
This article is cited by
-
Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant glioma
Molecular Medicine (2021)
-
Isocitrate dehydrogenase 1 mutation enhances 24(S)-hydroxycholesterol production and alters cholesterol homeostasis in glioma
Oncogene (2020)
-
CPEM: Accurate cancer type classification based on somatic alterations using an ensemble of a random forest and a deep neural network
Scientific Reports (2019)